Generic Drug News and Research

RSS

Generic Drugs are official nonbrand names by which medicines are known. Generic names usually refer to the chemical name of the drug.

New York State moves closer to lower drug prices

It's a lot easier to negotiate a better price on something when you buy in volume -- that's the approach the State Assembly is hoping the state will take when buying its prescription drugs.

28 Feb 2007

Pfizer wins Norvasc patent challenge by Mylan

Pfizer said today that a federal court in the Western District of Pennsylvania (Pittsburgh) has upheld the company's U.S. patent covering the active ingredient in Norvasc

27 Feb 2007

Danish court injunction prohibits sale of generic Lipitor

Pfizer has announced that a Danish court has granted a preliminary injunction against Nomeco A/S -- the largest pharmaceutical wholesaler in Denmark -- that prohibits the sale of a generic version of Lipitor by generics manufacturer Ranbaxy.

25 Feb 2007

Thailand threatens big pharma companies

Thailand's minister for health has reportedly threatened to override international patents on even more drugs if the big pharmaceutical manufacturers do not significantly cut their prices.

19 Feb 2007

FDA warns consumers about buying medications over the Internet

The Food and Drug Administration (FDA) in the United States has again warned consumers about buying medications over the Internet.

19 Feb 2007

Countries should find balance between affordable drugs, development incentives, WHO Director-General says in letter to Thai Health Minister

World Health Organization Director-General Margaret Chan in a letter to Thai Health Minister Mongkol na Songkhla said that although the Thai government was fully within its rights to issue a compulsory license for Abbott Laboratories antiretroviral drug Kaletra, countries should find the "right balance" between providing affordable medicines and incentives for drug companies to develop new treatments.

19 Feb 2007

Legislation introduced that would give FDA authority to approve generic versions of biotechnology drugs

Lawmakers in the House and Senate on Wednesday introduced a bill that would allow FDA to approve generic versions of biotechnology medications, USA Today reports.

19 Feb 2007

Health care industry groups lobby Presidential candidates

Roll Call on Wednesday examined how health care is "quickly becoming a cornerstone" of 2008 presidential candidates' domestic proposals and how "health industry groups and their lobbyists already are trying to make sure candidates in both parties keep their interests in mind along the campaign trail."

19 Feb 2007

Thailand holds drug giants over a barrel

The government of Thailand, has already upset some of the big drug companies by overriding patent licenses for generic versions of heart and HIV/AIDS pills, and is now planning to go one step further unless drug giants cut their prices.

13 Feb 2007

GenoMed discovers African gene

GenoMed has announced that it has found the "African gene," responsible for the much higher incidence of diabetes, high blood pressure, and kidney failure among people of African ancestry than whites.

12 Feb 2007

WHO cautions Thailand against issuing compulsory license for antiretroviral Kaletra

The World Health Organization on Thursday cautioned the Thai government on its decision to allow the country to produce a lower-cost version of Abbott Laboratories' antiretroviral drug Kaletra by granting a compulsory license for the drug, the Bangkok Post reports.

7 Feb 2007

Most of Medicare and Medicaid savings in Bush's budget proposal come from reducing growth in Medicare provider payments

The "lion's share" of the Medicare and Medicaid savings over five years proposed in President Bush's fiscal year 2008 budget proposal comes from limits on annual inflation adjustments for reimbursements to hospitals, nursing homes and other health care providers for Medicare, amounting to $39.5 billion, CQ HealthBeat reports.

7 Feb 2007

GlaxoSmithKline issues update on US patent litigation regarding Valtrex

GlaxoSmithKline has issued an update on US patent litigation regarding Valtrex (valacyclovir), an antiviral drug used for the treatment and suppression of genital herpes, herpes zoster (shingles), and cold sores.

5 Feb 2007

Novartis' day in court could leave millions without AIDS drugs

The Swiss pharmaceutical giant Novartis is in court in India this week challenging the country's patent laws.

30 Jan 2007

Utah Senate approves bill to establish Medicaid preferred drugs

The Utah Senate on Wednesday unanimously approved a bill (SB 42) that would establish a preferred drug list for the state Medicaid program, the Deseret Morning News reports.

30 Jan 2007

TV ads for drugs high on the emotions but low on facts

According to a new study television commercials for prescription drugs are heavily loaded on the emotional side but offer scant information on the disease itself and do little to promote the benefits of a healthy lifestyle.

30 Jan 2007

Thailand the latest drug patent buster

Thailand's military government has used World Trade Organization (WTO) rules regarding intellectual property, to allow the sale of generic versions of two important drugs used to treat HIV/AIDS and heart disease.

29 Jan 2007

AIDS Healthcare Foundation praises Thai action on AIDS drug licensing

AIDS Healthcare Foundation (AHF), the US' largest HIV/AIDS healthcare and prevention and education provider, which operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia, praised the Government of Thailand for its plan to break the patents on some lifesaving drugs, including one for an anti- retroviral drug used in the treatment of HIV/AIDS.

29 Jan 2007

Favorable decision for Ranbaxy on Atorvastatin patent in Canada

Ranbaxy Laboratories Limited announced that the Federal Court of Canada has handed down a favorable decision in the company's case against Pfizer by finding invalid Pfizer's Canadian atorvastatin patent CA 2,021,546.

28 Jan 2007

Massachusetts health insurance law could cost more than anticipated

Monthly premiums under the proposed minimum requirements for the new Massachusetts health insurance law would cost an estimated $380 on average for an individual, according to a state panel, the Boston Globe reports.

23 Jan 2007